Low antimicrobial resistance rates of Mycobacterium tuberculosis complex between 2000 and 2015 in Gipuzkoa, northern Spain
- PMID: 30850232
- DOI: 10.1016/j.eimc.2019.01.016
Low antimicrobial resistance rates of Mycobacterium tuberculosis complex between 2000 and 2015 in Gipuzkoa, northern Spain
Abstract
Objective: Although the incidence of tuberculosis (TB) has declined, TB drug resistance remains a major problem. The TB rate in Gipuzkoa (northern Spain) is higher than the European average. The objective of this study was to determine the antimicrobial susceptibility of 1855 Mycobacterium tuberculosis complex isolates (94.5% of confirmed cases between 2000 and 2015).
Methods: Susceptibility testing was performed using the agar proportion method and a commercial broth system (MGIT 960). In isoniazid- or rifampicin-resistant strains, we studied genetic determinants of drug resistance and genotype (MIRU-VNTR).
Results: The annual mean incidence of TB was 24.5 cases per 100,000 population on average, and tended to decrease. The multidrug-resistant TB rate was 0.5% (9/1855), and no extensively drug-resistant TB strains were detected. Rates of resistance to isoniazid and rifampicin were 3.9% (range, 3.4-4.3%) and 0.6% (range, 0.4-1.4%), respectively. TB resistance was more common among foreign-born individuals and those who had received previous TB treatment. Genotyping of 102 resistant strains showed predominance of the Euro-American lineage, although 4/9 multidrug-resistant strains had Eastern lineages (2 East African-Indian, and 2 East Asian [Beijing]).
Conclusions: In Gipuzkoa, with a moderate incidence of TB, resistance was very low, mostly being detected among individuals who were born abroad or who had a history of TB treatment.
Keywords: Drug-resistant tuberculosis; Epidemiology; Epidemiología; Microbial sensitivity test; Multidrug-resistant tuberculosis; Susceptibilidad antibiótica; Tuberculosis multirresistente; Tuberculosis resistente.
Copyright © 2019 Elsevier España, S.L.U. and Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica. All rights reserved.
Similar articles
-
Analysis of Mycobacterium tuberculosis genetic lineages circulating in Riga and Riga region, Latvia, isolated between 2008 and 2012.Infect Genet Evol. 2020 Mar;78:104126. doi: 10.1016/j.meegid.2019.104126. Epub 2019 Nov 26. Infect Genet Evol. 2020. PMID: 31783188
-
Molecular characterization of multidrug-resistant Mycobacterium tuberculosis (MDR-TB) isolates identifies local transmission of infection in Kuwait, a country with a low incidence of TB and MDR-TB.Eur J Med Res. 2019 Dec 5;24(1):38. doi: 10.1186/s40001-019-0397-2. Eur J Med Res. 2019. PMID: 31806020 Free PMC article.
-
Comparison of the socio-demographic and clinical features of pulmonary TB patients infected with sub-lineages within the W-Beijing and non-Beijing Mycobacterium tuberculosis.Tuberculosis (Edinb). 2016 Mar;97:18-25. doi: 10.1016/j.tube.2015.11.007. Epub 2015 Dec 23. Tuberculosis (Edinb). 2016. PMID: 26980491
-
[Resistance to first-line drugs and major genotypic lineages of Mycobacterium tuberculosis in the 3 French Department of the Americas: Profiles, evolution, and trends (1995-2011)].Bull Soc Pathol Exot. 2014 May;107(2):90-105. doi: 10.1007/s13149-014-0339-8. Epub 2014 Mar 13. Bull Soc Pathol Exot. 2014. PMID: 24627041 Review. French.
-
Whole genome sequencing for the management of drug-resistant TB in low income high TB burden settings: Challenges and implications.Tuberculosis (Edinb). 2017 Dec;107:137-143. doi: 10.1016/j.tube.2017.09.005. Epub 2017 Sep 18. Tuberculosis (Edinb). 2017. PMID: 29050762 Review.
Cited by
-
Novel Zinc(II) and Copper(II) Complexes of 2-((2-Hydroxyethyl)amino)quinoline-3-carbaldehyde for Antibacterial and Antioxidant Activities: A Combined Experimental, DFT, and Docking Studies.ACS Omega. 2022 Jul 19;7(30):26336-26352. doi: 10.1021/acsomega.2c02205. eCollection 2022 Aug 2. ACS Omega. 2022. PMID: 35936450 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical